Ana Barac, MD, PhD, is an Associate Professor of Medicine and Oncology at Georgetown University and the director of the MedStar Heart and Vascular Institute's Cardio-Oncology program. Her clinical and research interests focus on the mechanisms, diagnosis and treatment of cardiac complications of cancer therapies.
Dr. Barac is internationally recognized for her work on cardiovascular health in patients with cancer. She is the current and founding Chair of the American College of Cardiology (ACC) Cardio-Oncology Council. She also serves as the co-director of the ACC's annual Live Course on Advancing Cardiovascular Care in Oncology patient and was the chair of the Heart House Roundtable on Cardiovascular Disease and Cancer Treatment in February 2018. She is an Associate Editor of the Journal of Cardiovascular Translational Research, is on the Editorial Board of the Journal of the American College of Cardiology and serves as an Associate Editor of the new JACC: Cardio-Oncology.
Dr. Barac has a background in basic science research on signaling pathways and was a visiting research fellow at the National Institutes of Health. In 2013 she was awarded a KL2 Scholar Award from the Georgetown-Howard Universities Center for Clinical and Translational Science for investigation of cardiac function in women, BRCA-mutation carriers who were treated with anthracyclines.
She served as the cardiology principal investigator (PI) for the SAFE-HEaRt trial, an investigator-initiated study that investigates safety of HER2 targeted therapies in patients with HER2 positive breast cancer and reduced cardiac function.
Dr. Barac is a diplomate in Cardiovascular Disease and has advanced training in Cardiac Imaging, Echocardiography and Cardiac MRI.
Contact info:
110 Irving Street Northwest
Suite NW
Washington, DC, 20010(202) 877-7777